These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 25039352)
1. Diabetes insipidus in myelodysplastic syndrome: what we learnt from a case regarding its diagnosis, pathophysiology and management. Chuang C; Parnerkar V; Radulescu A; Hunt MA; Cayci Z; Ustun C Leuk Lymphoma; 2015 Apr; 56(4):1134-6. PubMed ID: 25039352 [No Abstract] [Full Text] [Related]
2. [Improvement of diabetes insipidus after allogeneic bone marrow transplantation in a patient with myelodysplastic syndrome]. Sato N; Takayama N; Kizaki M; Ikeda Y; Okamoto S Rinsho Ketsueki; 2003 May; 44(5):318-22. PubMed ID: 12822406 [TBL] [Abstract][Full Text] [Related]
3. Second allogeneic stem cell transplantation in a patient with hypoplastic myelodysplastic syndrome following a primary diagnosis of aplastic anaemia. Ocheni S; Oyekunle A; Kröger N; Ayuk F; Klyuchnikov E; Arps S; Held K; Zabelina T; Adjallé R; Wolschke C; Zander AR; Bacher U Acta Haematol; 2011; 125(3):175-8. PubMed ID: 21196720 [No Abstract] [Full Text] [Related]
4. Allogeneic stem cell transplantation in a patient with myelodysplastic syndrome and polyarteritis nodosa: a case report and systematic review. Stavenga M; Leavis HL; de Witte TM; Raymakers RA Ann Hematol; 2016 Mar; 95(4):645-7. PubMed ID: 26787416 [No Abstract] [Full Text] [Related]
5. [Myelodysplastic syndrome, diabetes insipidus, and progressive deficit of hypothalamic dysfunction]. Arrieta FJ; Calero MA; Krisnik I; Saavedra MP An Med Interna; 2002 Sep; 19(9):495-7. PubMed ID: 12420646 [No Abstract] [Full Text] [Related]
6. Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges. Shah NN; Bacher U; Fry T; Calvo KR; Stetler-Stevenson M; Arthur DC; Kurlander R; Baird K; Wise B; Giralt S; Bishop M; Hardy NM; Wayne AS Am J Hematol; 2012 Sep; 87(9):916-22. PubMed ID: 22473867 [No Abstract] [Full Text] [Related]
7. Allogeneic Hematopoietic Cell Transplantation Is Safe and Effective Treatment in Patients with Myelodysplastic Syndromes Seventy Years and Older. Mukherjee S Biol Blood Marrow Transplant; 2017 Jan; 23(1):1-2. PubMed ID: 27865911 [No Abstract] [Full Text] [Related]
8. Selection of Patients With Myelodysplastic Syndrome for Allogeneic Hematopoietic Stem Cell Transplantation. Mishra A; Anasetti C Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S49-52. PubMed ID: 27521324 [TBL] [Abstract][Full Text] [Related]
17. The diagnosis and management of diabetes insipidus during medical emergencies. Buonocore CM; Robinson AG Endocrinol Metab Clin North Am; 1993 Jun; 22(2):411-23. PubMed ID: 8325295 [TBL] [Abstract][Full Text] [Related]
19. Management of Myelodysplastic Syndrome Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: A Study by the French Society of Bone Marrow Transplantation and Cell Therapies. Guièze R; Damaj G; Pereira B; Robin M; Chevallier P; Michallet M; Vigouroux S; Beguin Y; Blaise D; El Cheikh J; Roos-Weil D; Thiebaut A; Rohrlich PS; Huynh A; Cornillon J; Contentin N; Suarez F; Lioure B; Mohty M; Maillard N; Clement L; François S; Guillerm G; Yakoub-Agha I Biol Blood Marrow Transplant; 2016 Feb; 22(2):240-247. PubMed ID: 26256942 [TBL] [Abstract][Full Text] [Related]
20. Diabetes insipidus in a child with a monosomy-7 associated myelodysplastic syndrome and neurofibromatosis I. Kollen WJ; Ball LM; Snijder P; van Zelderen-Bhola SL; Egeler RM Med Pediatr Oncol; 2003 Apr; 40(4):257-9. PubMed ID: 12555259 [No Abstract] [Full Text] [Related] [Next] [New Search]